Mechanisms of disease: The pathogenesis of vasodilatory shock

New England Journal of Medicine

Volumn 345, Issue 8, 2001, Pages 588-595

  Landry, Donald W ^a   Oliver, Juan A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON MONOXIDE; CYANIDE; GLUCOCORTICOID; METFORMIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN; POTASSIUM CHANNEL; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

BLOOD VESSEL TONE; HEMORRHAGIC SHOCK; HUMAN; HYPOXIA; INTOXICATION; LACTIC ACIDOSIS; MEMBRANE POTENTIAL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SHOCK; VASCULAR SMOOTH MUSCLE; VASODILATATION; ANIMAL; BIOSYNTHESIS; HYPOTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION;

ANIMALS; HUMANS; HYPOTENSION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; POTASSIUM CHANNELS; SHOCK; VASOCONSTRICTION; VASODILATION; VASOPRESSINS;

EID: 0035940129     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra002709     Document Type: Review

References (77)

1. Hemodynamic measurements in septic shock
2. The cardiovascular response of normal humans to the administration of endotoxin
3. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog
4. Hypoxic and CO hypoxia in dogs: Hemodynamics, carotid reflexes, and catecholamines
5. Some circulatory responses to hemorrhage in the dog
6. The pathophysiology of irreversible hemorrhagic shock in monkeys
7. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide
8. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement
9. Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass
10. Hemodynamic studies in cardiogenic shock: Treatment with isoproterenol and metaraminol
11. Role of metformin accumulation in metformin-associated lactic acidosis
12. Hyperglycemic acidotic coma and death in Kearns-Sayre syndrome
13. Cyanide intoxication in Macaca mulatta: Physiological and neuropathological aspects
14. Electromechanical dissociation in human beings: An echocardiographic evaluation
15. Arterial norepinephrine changes in patients with septic shock
16. Vasoactive hormones in the renal response to systemic sepsis
17. Shock
18. Pathogenetic mechanisms of septic shock
19. The effects of ibuprofen on the physiology and survival of patients with sepsis
20. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study
21. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS
22. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ia
23. Ion channels and vascular tone
24. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle
25. Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular protons
26. Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes
27. Cardiovascular effects of conventional sulfonylureas and glimepiride
28. Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: Effects of pre- or post-treatment with glibenclamide
29. ATP-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock
30. Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock
31. Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock
32. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock
33. Effects of severe hemorrhage on plasma ANP and glomerular ANP receptors
34. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels
35. Nitrogen oxide levels in patients after trauma and during sepsis
36. Nitric oxide in septic shock
37. Altered immune responses in mice lacking inducible nitric oxide synthase
38. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
39. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharideinduced death
40. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene
41. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells
42. Nitric oxide synthase inhibitors a mechanism-based treatment of septic shock
43. Modulating the L-arginine-nitric oxide pathway in septic shock: Choosing the proper point of attack
44. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
45. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase
46. Calcium sparks in smooth muscle
47. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats
48. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats
49. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase
50. +-channels in vascular hyporeactivity induced by endotoxin
51. Vasopressin clearance and secretion during haemorrhage in normal dogs and in dogs with experimental diabetes insipidus
52. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock
53. Effect ofvasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs
54. Microvascular vasopressin effects during endotoxin shock in the rat
55. The role of vasopressin in the maintenance of cardiovascular function during early endotoxin shock
56. Effect of captopril on cardiovascular, sympathetic and vasopressin responses to hemorrhage
57. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock
58. Vasopressin deficiency contributes to the vasodilation of septic shock
59. Vasopressin response to orthostatic hypotension: Etiologic and clinical implications
60. Plasma endothelin during upright tilt: Relevance for orthostatic hypotension?
61. The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unanaesthetized monkey (Macaca mulatta)
62. Reversible vasopressin deficiency in severe hypernatremia
63. Dehydration-induced changes in immunoreactive vasopressin levels in specific hypothalamic structures
64. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors
65. Vasopressin administration in refractory cardiac arrest
66. The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension
67. Changes ofvasopressin in hypertension: Cause or effect?
68. Blood pressure in acute the syndrome of inappropriate antidiuretic hormone secretion N, chronic vasopressin excess: Studies of malignant hypertension
69. The effects ofrenin and angiotonin during hemorrhagic hypotension and shock
70. Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog
71. Spectral analysis of heart rate variability in the sepsis syndrome
72. Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip
73. +-channel activities of cultured smooth muscle cells from porcine coronary artery
74. 1 receptor in cultured rat mesangial cells
75. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line
76. Use of nitric oxide synthase inhibitors to treat septic shock: The light has changed from yellow to red